Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s footer/site revision tag was updated from **v3.5.2** to **v3.5.3**, indicating a general system release rather than a change to the clinical trial record.
    Difference
    0.0%
    Check dated 2026-04-24T06:33:29.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:50:32.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Added 'B-cell chronic lymphocytic leukemia' to the study's Conditions section.
    Difference
    0.0%
    Check dated 2026-04-02T15:43:23.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated to v3.5.0, replacing the previous v3.4.3 revision.
    Difference
    0.0%
    Check dated 2026-03-19T06:40:58.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:02.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Study status updated to Completed; results have been posted and enrollment and completion dates updated.
    Difference
    0.0%
    Check dated 2026-03-04T23:42:54.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.